Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for sleep problems and nightmares in patients with depressive disorder
IRCT20210409050910N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in major depressive disorder (MDD) and sleep disorder comparing Prazosin plus routine antidepressants with Placebo plus routine antidepressants (2 arms). Primary endpoints: Sleep-related symptom frequency and Sleep quality by Pittsburgh questionnaire. Started Apr 2021; status: completed.
02
Drugs
prazosin
03
Conditions
major depressive disorder (MDD)sleep disorder
Beyond the preview
Go deeper on IRCT20210409050910N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210409050910N1.